XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer

Chinese Medical Journal

Volumn 124, Issue 20, 2011, Pages 3238-3243

  Chen, Yong Bing ^a   Shu, Jian ^a   Yang, Wen Tao ^a   Shi, Li ^a   Guo, Xu Feng ^a   Wang, Fei Ge ^a   Qian, Yong Yue ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Biomarker; Cell proliferation; Human lung cancer cell lines; Prognosis; XAF1

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; MESSENGER RNA; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; X LINKED INHIBITOR OF APOPTOSIS ASSOCIATED FACTOR 1;

ADENOVIRUS 5; ADULT; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER GRADING; CANCER INHIBITION; CANCER STAGING; CANCER TISSUE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; X LINKED INHIBITOR OF APOPTOSIS ASSOCIATED FACTOR 1 GENE;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NEOPLASMS, SQUAMOUS CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80054854591     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.20.006     Document Type: Article

References (30)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
2. Kaufmann SH, Vaux DL. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 2003; 22: 7414-7430.
3. Salvesen GS. Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 2002; 9: 3-5.
4. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470.
5. Bilim V, Kasahara T, Hara N, Takahashi K, Tomita Y. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer 2003; 103: 29-37.
6. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 2001; 3: 128-133.
7. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70: 113-122.
8. Byun DS, Cho K, Ryu BK, Lee MG, Kang MJ, Kim HR, et al. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res 2003; 63: 7068-7075.
9. Ma TL, Ni PH, Zhong J, Tan JH, Qiao MM, Jiang SH. Low expression of XIAP-associated factor 1 in human colorectal cancers. Chin J Dig Dis (Chin) 2005; 6: 10-14.
10. Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006; 131: 1835-1843.
11. Kempkensteffen C, Hinz S, Schrader M, Christoph F, Magheli A, Krause H, et al. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome. Cancer Lett 2007; 254: 227-235.
12. Huang J, Yao WY, Zhu Q, Tu SP, Yuan F, Wang HF, et al. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer. Cancer Sci 2010;101: 559-567.
13. Lee MG, Huh JS, Chung SK, Lee JH, Byun DS, Ryu BK, etal. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses. Oncogene 2006; 25: 5807-5822.
14. Tu SP, Sun TW, Cui JT, Zou B, Lin MC, Gu Q, et al. Tumor suppressor XIAP-associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression. Cancer 2010; 116: 1252-1263.
15. Tu SP, Liston P, Cui JT, Lin MC, Jiang XH, Yang Y, et al. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer. Int J Cancer 2009; 125: 688-697.
16. Sun PH, Zhu LM, Qiao MM, Zhang YP, Jiang SH, Wu YL, et al. The XAF1 tumor suppressor induces autophagic cell death via upregulation of beclin-1 and inhibition of AKT pathways. Cancer Lett, 2011, Epub July 5. doi:10.1016/j.canlet.2011. 06.037
17. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
18. Green DG, Evan GI. A matter of life and death. Cancer Cell 2002; 1: 19-30.
19. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277-288.
20. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3: 401-410.
21. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300-304.
22. Suzuki Y, Nakabayashi Y, Nakata K, Reed JC, Takahashi R. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and-7 in distinct modes. J Biol Chem 2001; 276: 27058-27063.
23. Karikari CA, Roy I, Tryggestad E, Feldmann G, Pinilla C, Welsh K, et al. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther 2007; 6: 957-966.
24. Du C, Fang M, Li Y, Li L,Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.
25. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001; 8: 613-621.
26. Leaman DW, Chawla-Sarkar M, Vyas K, Reheman M, Tamai K, Toji S, et al. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J Biol Chem 2002; 277: 28504-28511.
27. Chung SK, Lee MG, Ryu BK, Lee J, Han J, Byun DS, et al. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses. Gastroenterology 2007; 132: 2459-2477.
28. Xia Y, Novak R, Lewis J, Duckett CS, Phillips AC. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP. Mol Cell Biochem 2006; 286: 67-76.
29. Ng KC, Campos EI, Martinka M, Li G. XAF1 expression is significantly reduced in human melanoma. J Invest Dermatol 2004; 123: 1127-1134.
30. Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, et al. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. J Clin Oncol 2006; 24: 3771-3779.